CNR Institutional Research Information System

POCHETTI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.571
NA - Nord America 873
SA - Sud America 309
EU - Europa 265
AF - Africa 28
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.049
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 834
SG - Singapore 682
CN - Cina 343
BR - Brasile 255
VN - Vietnam 179
HK - Hong Kong 163
FR - Francia 89
KR - Corea 77
NL - Olanda 36
IT - Italia 28
FI - Finlandia 25
IN - India 25
AR - Argentina 24
GB - Regno Unito 24
JP - Giappone 18
DE - Germania 17
ID - Indonesia 17
BD - Bangladesh 16
CA - Canada 14
IQ - Iraq 10
MX - Messico 10
EC - Ecuador 9
PL - Polonia 7
ZA - Sudafrica 7
EG - Egitto 6
IL - Israele 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
PT - Portogallo 5
AT - Austria 4
CL - Cile 4
CR - Costa Rica 4
KE - Kenya 4
MA - Marocco 4
RU - Federazione Russa 4
UA - Ucraina 4
VE - Venezuela 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
SA - Arabia Saudita 3
SE - Svezia 3
CZ - Repubblica Ceca 2
ES - Italia 2
HN - Honduras 2
KG - Kirghizistan 2
MY - Malesia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CD - Congo 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LT - Lituania 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 3.049
Salva come PNG Salva come JPEG
Città #
Santa Clara 466
Singapore 406
Hefei 163
Hong Kong 160
Lauterbourg 80
San Jose 78
Seoul 77
Ho Chi Minh City 64
Beijing 52
Hanoi 51
Ashburn 45
Los Angeles 26
São Paulo 20
Dallas 13
Buffalo 12
Da Nang 12
Helsinki 11
Chicago 9
Rio de Janeiro 9
Tokyo 9
Frankfurt am Main 8
Turku 8
Minamishinagawa 7
New York 7
Belo Horizonte 6
Haiphong 6
Lappeenranta 6
Chennai 5
Guayaquil 5
Manchester 5
Mumbai 5
Warsaw 5
Blumenau 4
Brasília 4
Buenos Aires 4
Campinas 4
Curitiba 4
Houston 4
Johannesburg 4
London 4
Montreal 4
Nairobi 4
Ninh Bình 4
Orem 4
Rome 4
Thái Bình 4
Amsterdam 3
Biên Hòa 3
Bogotá 3
Bom Despacho 3
Boston 3
Brooklyn 3
Caxias do Sul 3
Corrientes 3
Delhi 3
Dhaka 3
Dubai 3
Düsseldorf 3
Fortaleza 3
Guarulhos 3
Hamilton 3
Hortolândia 3
Hải Dương 3
Jakarta 3
Joinville 3
Juiz de Fora 3
Lima 3
Poplar 3
Porto Alegre 3
Quito 3
Shanghai 3
Stockholm 3
Tampa 3
The Bronx 3
The Dalles 3
Thái Nguyên 3
Tirana 3
Atlanta 2
Baghdad 2
Bahía Blanca 2
Bengaluru 2
Bishkek 2
Campos dos Goytacazes 2
Can Tho 2
Casablanca 2
Covington 2
Dublin 2
Greenville 2
Gujranwala 2
Heredia 2
Jeddah 2
Jequié 2
Lajeado 2
Maceió 2
Manaus 2
Medellín 2
Memphis 2
Mexico City 2
Mosul 2
Newham 2
Totale 2.031
Salva come PNG Salva come JPEG
Nome #
Insights into PPARgamma Phosphorylation and Its Inhibition Mechanism 92
Regulation of gene expression in the liver and adipose tissue by a new dual PPARalpha/gamma agonist 72
Pha-680626 is an effective inhibitor of the interaction between aurora-a and n-myc 70
On the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands. 67
Resveratrol and Its Metabolites Bind to PPARs 65
Conformational studies of synthetic leucinostatin A fragments 64
Crystal Structures of the Complexes between PPARgamma and two new ligands with dual activity 63
Discovery of novel chemical series of oxa-48 beta-lactamase inhibitors by high-throughput screening 63
Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination 62
Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex 61
Screening of saponins and sapogenins from Medicago species as potential PPAR? agonists and X-ray structure of the complex PPAR?/caulophyllogenin 61
Water induced beta-turn modification in a chemotactic tetrapeptide. Synthesis, crystal conformation, and activity of HCO-Met-Leu-DeltaZPhe-Phe-OMe 59
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy 59
Betulinic acid is a PPARg antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis 55
Structural Insight into Peroxisome Proliferator-Activated Receptor ³ Binding of Two Ureidofibrate-Like Enantiomers by Molecular Dynamics, Cofactor Interaction Analysis, and Site-Directed Mutagenesis 54
Conformationally constrained analogues of endogenous tripeptide inhibitors of zinc metalloproteinases. 54
A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor gamma Binding Properties and Biological Activities 53
On the Metabolically Active Form of Metaglidasen: Improved Synthesis and Investigation of Its Peculiar Activity on Peroxisome Proliferator-Activated Receptors and Skeletal Muscles. 49
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 48
Structural basis of the transactivation deficiency of the human PPAR gamma F360L mutant associated with familial partial lipodystrophy 47
LT175 is a novel PPARalpha/gamma ligand with potent insulin-sensitizing effects and reduced adipogenic properties 46
Design and biophysical characterization of atrazine-sensing peptides mimicking the Chlamydomonas reinhardtii plastoquinone binding niche. 44
Identification of the first PPARa/g able to bind to canonical and alternate sites of PPARg and to inhibit its Cdk-5-mediated phosphorylation 44
Metalloproteinase Inhibitors, their Therapeutic Use and Process for the Production of the Starting Compound in the Synthesis Thereof 42
New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists able ti up regulate the mitochondrial carnitine shuttle system gene expression. 40
Crystal Structure of PPARgamma Ligand Binding Domain complexed with a novel Partial Agonist: a new region of the hydrophobic pocket could be exploited for drug design 40
Inhibitors of Metalloproteinase, their Therapeutic Use, and Process for the Production of the Starting Compound in the Synthesis 39
Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode. 39
Crystal structure of the PPAR-gamma ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design 37
Open tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors alpha and gamma for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection 37
Affinity-Based Separation Methods for the Study of Biological Interactions: the case of Peroxisome Proliferator-Activated Receptors in drug discovery 36
The monoclinic phase of the 2/1 inclusion compound between deoxycholic acid and o-xylene 36
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8. 31
2 Angstrom X-ray structure of adamalysin II complexed with a peptide phosphonate inhibitor adopting a retro-binding mode 29
Structure and conformation of peptides containing the sulphonamide junction. I. N-acetyl-tauryl-L-phenylalanine methyl ester. 29
Structure of a triclinic phase of sodium dodecyl sulfate monohydrate. A comparison with other sodium dodecyl sulfate crystal phases 29
Frontal affinity chromatography with MS detection of the ligand binding domain of PPARg receptor: Ligand affinity screening and stereoselective ligand-macromolecule interaction. 29
Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands. 29
Structural studies of a human chimeric plasminogen activator Amediplase (k2tu-PA) 29
Topographically constrained aromatic-alpha-aza-amino acids. Synthesis, molecular structure, and conformation of two azaTic derivatives 28
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists 28
Structure and conformation of peptides containing the sulphonamide junction. IV. Synthesis and crystal conformation of N-benzoyl-L-Phenylalanyl-Tauryl-L-Leucine Methyl Ester 27
Gamma-Turn Conformation Induced by ,-Disubstituted Amino Acids with a Cyclic Six-Membered Side Chain 27
Structure of the 4:1 inclusion compound between deoxycholic acid and (E)-p-dimethylaminobenzene 27
Computational study of the catalytic domain of human neutrophil collagenase. Specific role of the S3 and S3' subsites in the interaction with a phosphonate inhibitor 27
Peptides containing the sulfonamide junction: synthesis, structure, and conformation of Z-Tau-Pro-Phe-NHiPr 26
New 2-Aryloxy-3-phenyl-propanoic Acids As Peroxisome Proliferator-Activated Receptors alpha/gamma Dual Agonists with Improved Potency and Reduced Adverse Effects on skeletal muscle function 26
Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor-gamma ligand-binding domain in the complex with two enantiomeric ligands 26
SYNTHESIS, Characterization and biological evaluation of ureidofibrate-like derivatives endowed with Peroxisome Proliferator-Activated Receptor Activity 26
Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: implications for drug design. 25
Internal .beta.-Turn Hydration: Crystallographic Evidence and Molecular Dynamics Simulation 25
Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides. 25
Molecular organization of sodium dodecylsulfate in crystal phases 24
Partial agonism in PPARs: the role of helix 3 24
A reinvestigation of the reaction of N-(2-bromoethyl)isatoic anhydride with methyl amine. Isolation and crystal structure of 1-(2-hydroxyethyl)-3-methyl-2,4-(1H,3H)-Quinazolinedione 24
Improved lipid metabolism and reduced fat deposition in a mouse model of diet-induced obesity (DIO) with a new dual PPARalpha/gamma ligand 24
Retrosulfonamido peptide analogues. Synthesis and crystal conformation of Boc-Pro-Leu-psi(NH-SO2)-Gly-NH2 24
Structural studies of Leucinostatin A and its Boc-Aib-Leu-Leu-Aib-OMe tetra peptide fragment 24
Identification of novel dual peroxisome proliferator-activated receptor alpha/gamma ligands and characterization of their biochemical properties by 3D structural studies 24
Studies on the activity of a new ligand of the peroxisome proliferator-activated receptors (PPARs) 24
For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. 23
Modified chemotactic peptides: synthesis, conformation, and biological activity of For-Thp-Leu-delta ZPhe-OMe. 23
N-Acyl-diketopiperazines. II. Crystal structure and conformation of N-(pyruvoyl)-cyclo-(L-Phenylalanyl-D-Prolyl) 23
Phosphonate inhibitors of adamalysin II and matrix metalloproteinases. 23
For-Met-DeltazLeu-Phe-OMe: A new active analog of chemotactic N-formyltripeptides with beta-turn crystal conformation 23
Crystal structure, conformation, and potential energy calculations of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OMe. 23
Crystal phases obtained from aqueous solutions of sodium dodecyl sulfate. The structure of a monoclinic phase of sodium dodecyl sulfate hemihydrate 22
Structural modification and conformational features of chemotactic N-formylpeptides 22
Structure and conformation of peptides containing the sulphonamide junction. III. Synthesis, crystal and molecular structure of a taurine containing peptidic oxa-cyclol. 22
The inclusion compound of deoxycholic acid with (-)-camphor: a structural and energetic study 22
The structure of 2/1 'Channel' Inclusion Compound between Deoxycholic Acid and Pinacolone, 2C24H40O4.C6H12O 22
Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. 22
Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'-(methylthio)ethyl]methionine residue 22
Structural studies of chemotactic oligopeptides. Crystal, molecular structure and energy calculations of N-Formyl-Methionyl-Leucyl-Phenylalanyl methyl ester 21
Synthesis and structural studies of N-p-Toluensulfonyl cyclodipeptides 21
New chemotactic peptide analogs with high biological activity for human neutrophils. 21
Prochiral selectivity in H2O2-promoted oxidation of arylalkanols catalysed by chloroperoxidase 21
Stereoselectivity by enantiomeric inhibitors of matrix metalloproteinase-8: new insights from molecular dynamics simulations 21
Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe. 21
Novel dual PPARalpha/gamma agonists, as potential hypoglycemic and anti diabetic agents 20
Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe. 20
Potential energy calculations on phenylalanine rotamers in different boat forms of proline-containing cyclic dipeptides. 20
Structural insight into the crucial role of ligand chirality in the activation of PPARs by crystallographic methods 20
Inhibition of Adamalysin II and MMPs by phosphonate analogues of snake venom peptides 20
Endoannular reactions and ring-chain tautomerism. Structure of 1-(2-Hydroxyethyl)-3-methyl-2,4(1H,3H)-quinazolinedione 20
Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues. 19
Structure and conformation of peptides containing the sulfonamide junction. II. Synthesis and conformation of cyclo[-MeTau-Phe-DPro-]. 19
Overexpression system and biochemical profile of CTX-M-3 extended-spectrum beta-lactamase expressed in Escherichia coli. 19
Synthesis and properties of chemotactic peptide analogs. I. Crystal structure and molecular conformation of HCO-Met-leu-Ain-OMe. 18
Studies related to cephalosporins. 6(1). Bromination of 3-exomethylene in cepham derivatives 17
On the mechanism of partial agonism: crystal structures of the peroxisome proliferators-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands 17
Totale 3.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.812
article - articoli 8.176
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20247 0 0 0 0 0 0 0 0 2 0 2 3
2024/20251.295 1 8 78 62 382 107 15 30 38 47 283 244
2025/20261.783 118 179 254 296 319 31 285 101 92 72 36 0
Totale 3.085